Our Company
Securecell is a trusted partner for biopharma, enabling new therapies to be delivered to patients in a safe, efficient, and economical way. We engineer ground-breaking measuring and control technologies to radically improve bioprocessing, medical treatment, and patient health.
For more than 25 years, we have provided innovative bioprocessing solutions for biotech, pharma and academia. This expertise and experience has built a solid foundation for the transfer of next-gen biotechnologies into the Medtech field and a broader reach for our most important innovations.
“A great invention can only serve those within reach. Foresight, scaleability, and cooperation are integral tools of grand design, and a vital part of our mission”
- Carlo Andretta, Ph.D.
CEO & Founder
OUR MISSION:
Create ingenious technologies
to improve lives on a global scale.
FACTS & FIGURES
>95
Company
Innovators
>1'000
Installations
across big pharma,
biotech, academia
and CDMOs
>6'000
Integrated
hardware and
software solutions
in-use
MILESTONES IN OUR COMPANY HISTORY
-
2010
Incorporation of Securecell AG. Start of the MedTech business unit to develop a novel diabetes treatment
-
2020
Collaboration with Roche Custom Biotech focused on automated sampling & on-line analytics for bioprocesses
Learn more -
2022
Partnership with DataHow AG to accelerate bioprocess development through machine learning-based models
Learn more -
2023
First animal trial with Seraccess: automated blood sampling including glucose measurement
Learn more -
2024
Partnership with CGT Catapult Ltd. (UK) and DataHow AG for the integration of new digitization and PAT in cell and gene therapy
Learn more -
2024
Securecell launches novel high-throughput Bioprocessing solutions Intega1 64 and SampleBus.
Learn more